The EXSCALATE4CoV (E4C) project

The E4C consortium, coordinated by Dompé Farmaceutici, is composed by 18 institutions from seven European countries. At the core of E4C is Exscalate (EXaSCale smArt pLatform Against paThogEns), at present the most powerful and cost-efficient intelligent supercomputing platform in the world.

State of the art of the project

(*) EXSCALATE4COV + COVIRAL grants

JOIN E4C CONSORTIUM TO HELP
IDENTIFY NEW TREATMENTS
AGAINST SARS-COV-2

The information you provide will be used as input
into our High Performance Computing resources for
virtual screening against priority target
protein structures.

THE MEMBERS OF CONSORTIUM
ARE COMMITTED TO OPEN
ACCESS PUBLISHING

As part of its dissemination plan, E4C consortium is
making a repository available here for publications
originating from the project's activities following green
open access principles.

RESULTS

 

SIB Swiss Institute of Bioinformatics

Summary
Generation of homology models based on the mapped functional proteins of the entire sequenced SARS-CoV-2 viral genome

READ MORE    

 

Fraunhofer ITMP

Summary
Identification of inhibitors of SARS-CoV-2 3CL-Pro enzymatic activity using a repurposing screen (“target confirmation of main protease”)

READ MORE    

 

PHENOTYPIC SCREEN

No results yet



READ MORE    

 

ELETTRA SINCROTRONE TRIESTE

Summary
The structural biology team of Elettra Sincrotrone Trieste has focused on SARS-CoV-2 Mpro viral protein by setting up a reproducible expression, purification and crystallization protocol and using thermal stability profiling to define protein quality control and batch to batch reproducibility.

READ MORE    

 

BSC

Summary
Main activities performed in WP5 include the use of techniques for molecular evolution, phylogenetic and multiple correspondence analysis (MCA) for the identification of genomic and protein sites associated with SARS-CoV-2 adaptation and host-pathogen interaction.

READ MORE    

 

MECHANISM OF ACTION

No results yet



READ MORE    

 

AUTOMATED HOMOLOGY MODELING WORKFLOW FOR DRUG TARGET

No results yet


READ MORE    

 

POLIMI, CINECA

Summary
n the WP8 “Production and tuning on HPC infrastructure”, the POLIMI team is responsible for the continuous tuning and code adaptation of the EXSCALATE platform, and contributes to its porting on the new Marconi100 partition at CINECA.

READ MORE    

 

Dompé Farmaceutici

Raloxifene

Raloxifene has emerged from the Exscalate platform as a molecule with potential effectiveness against SARS-CoV-2, based on antiviral targeting.

READ MORE    

 

CHELONIA

Summary
Setup and Maintenance of Website & Social Media (D10.1).

READ MORE    

Consortium

League

DISCOVER OUR TASKFORCE


   

Address

Exscalate4cov
c/o Dompé Farmaceutici
Via Pietro Castellino, 111
80131 Napoli, Italy